Kantum Pharma, Inc.

New Filing
CIK: 0001747673·Biotechnology·DELAWARE·Filed: Jul 13, 2021
Total Offering

$3,530,522

Amount Sold

$3,530,522

Investors

44

First Sale

Jun 30, 2021

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Andrea Franz
Related Person
Glenn Batchelder
Related Person
Jean-Francois Carbonneau
Related Person
Sylvie Breton
Related Person
Thomas Needham
Related Person
Cory Wallenstein
Related Person

Company

Kantum Pharma, Inc.

75 SOUTH MAIN STREET

CONCORD, NH, 03301

603-876-6200

SEC Filing

0001747673-21-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Kantum Pharma, Inc. Form D Filing — $3,530,522 | FilingFlow